RESPICIL

This brand name is authorized in Mexico

Active ingredients

The drug RESPICIL contains a combination of these active pharmaceutical ingredients (APIs):

1 Procaine benzylpenicillin
UNII 17R794ESYN - PENICILLIN G PROCAINE
Read about Procaine benzylpenicillin
2 Benzylpenicillin
UNII YS5LY7JF4N - PENICILLIN G SODIUM

Benzylpenicillin is a beta-lactam antibiotic. It is bacteriocidal by inhibiting bacterial cell wall biosynthesis. Penicillin resistance can be mediated by alteration of penicillin binding proteins or development of beta-lactamases.

Read about Benzylpenicillin
3 Metamizole sodium
UNII VSU62Z74ON - METAMIZOLE SODIUM

Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid.

Read about Metamizole sodium

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: MX Comisiรณn Federal para la Protecciรณn contra Riesgos Sanitarios Identifier(s): 41953

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.